Related Experiment Video
Updated: May 15, 2026
11:17
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Randomised trial of a clinical dosing algorithm to start anticoagulation with phenprocoumon
Angela Caduff Good1, Daniel Nobel, Stephan Krähenbühl
1Hospital Pharmacy, University Children's Hospital, Zurich, Switzerland. Angela.Caduff@kispi.uzh.ch
Swiss Medical Weekly
|January 10, 2013
Summary
Two computer-assisted dosing algorithms for phenprocoumon (a blood thinner) were validated. While safe, they did not outperform physician-guided anticoagulation, suggesting clinical data is key for safe dosing.
Area of Science:
- Pharmacology
- Clinical Medicine
- Medical Informatics
Background:
- Phenprocoumon is a vitamin K antagonist used for anticoagulation.
- Accurate initiation of phenprocoumon therapy is crucial to prevent thromboembolic events and bleeding.
- Computer-assisted dosing algorithms aim to optimize anticoagulation initiation.
Purpose of the Study:
- To prospectively validate two computer-assisted dosing algorithms for phenprocoumon initiation.
- To compare the efficacy and safety of these algorithms against physician-guided anticoagulation.
Main Methods:
- A randomized controlled trial involving inpatients requiring new anticoagulation.
- Patients were assigned to one of two computer-assisted dosing algorithms or a control arm (physician-guided).
- Primary outcome: time to achieve therapeutic anticoagulation (INR 2.0-3.0) without overshooting (INR >4.0) within 10 days.
Main Results:
- No significant difference in time to therapeutic INR between algorithm arms and the control arm (median 7 vs. 6 days, p=0.5).
- Similar rates of overshooting INR (3.8%, 1.9%, 4.3%) and 30-day mortality (0%, 1%, 2.2%) across groups.
- VKORC1 gene variants (c.-1639 G>A and c.-1453 G>A) were associated with loading and maintenance dose requirements.
Conclusions:
- Both validated algorithms provide safe initial phenprocoumon dosing.
- The algorithms were not superior to anticoagulation managed by trained physicians.
- Clinical parameters and INR response are powerful indicators for safe coumarin dosing; delaying initiation for genetic testing is not recommended.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:15Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...